Rapid HPLC analysis of the antiepileptic lamotrigine and its metabolites in human plasma.

A liquid chromatographic method with diode array detection (DAD) has been developed for the analysis of the antiepileptic agent lamotrigine (LTG) and its metabolites, lamotrigine 2-N-glucuronide and 2-N-methylated in plasma samples. The analytes were separated on a C8 RP column, using a mobile phase composed of methanol and a 0.45 mM, pH 3.5 phosphate buffer containing 0.17% triethylamine (24:76 v/v). Melatonin was used as the internal standard (IS). The DAD detector was set at 220 nm for the detection of all the analytes. A simple protein precipitation with methanol guaranteed high extraction yield values (>90%) and good purification from matrix interference. Good linearity was obtained in the 0.1-15.0 microg/mL range for LTG and lamotrigine 2-N-glucuronide and in the 0.1-2.0 microg/mL range for lamotrigine 2-N-methylated. The analytical method was validated in terms of precision, extraction yield, and accuracy. These assays gave RSD% values for precision always lower than 4.3% and mean accuracy higher than 80%. The method seems to be suitable for the analysis of plasma samples from patients treated with Lamictal.

[1]  O. Beck,et al.  Determination of Lamotrigine and its Metabolites in Human Plasma by Liquid Chromatography-Mass Spectrometry , 2006, Therapeutic drug monitoring.

[2]  J. Sidhu,et al.  The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. , 2006, British journal of clinical pharmacology.

[3]  M. Contin,et al.  Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  S. Bodhankar,et al.  Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. , 2005, Journal of pharmaceutical and biomedical analysis.

[5]  M. Furlanut,et al.  A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients. , 2005, Pharmacological research.

[6]  O. Y. Hu,et al.  Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  M. Raggi,et al.  Analysis of lamotrigine and its metabolites in human plasma and urine by micellar electrokinetic capillary chromatography , 2005, Electrophoresis.

[8]  M. Raggi,et al.  Analysis of antiepileptic drugs in biological fluids by means of electrokinetic chromatography , 2005, Electrophoresis.

[9]  P. Pennell,et al.  The impact of pregnancy and childbirth on the metabolism of lamotrigine , 2004, Neurology.

[10]  Vinod P. Shah,et al.  Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.

[11]  T. Tomson,et al.  Oral contraceptives reduce lamotrigine plasma levels , 2003, Neurology.

[12]  M. Raggi,et al.  Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction , 2002 .

[13]  T. Tomson,et al.  Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During Lactation , 2000, Epilepsia.

[14]  J. Duncan,et al.  New Antiepileptic Drugs , 1994, Annals of clinical biochemistry.

[15]  J. Taylor,et al.  Simultaneous determination of lamotrigine and its glucuronide and methylated metabolites in human plasma by automated sequential trace enrichment of dialysates and gradient high-performance liquid chromatography. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[16]  E. Perucca,et al.  The influence of dosage, age, and comedication on steady state plasma lamotrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response. , 1997, Therapeutic drug monitoring.

[17]  J. Posner,et al.  Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. , 1997, British journal of clinical pharmacology.

[18]  B. Meldrum Update on the Mechanism of Action of Antiepileptic Drugs , 1996, Epilepsia.

[19]  R. Ramsay,et al.  Pharmacokinetics and safety of lamotrigine (Lamictal®) in patients with epilepsy , 1991, Epilepsy Research.